ARCHIVES

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

Also C-Change new name for National Dialogue on Cancer.

January 16, 2004

In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group

September 17, 1976

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005